Search

Your search keyword '"Gal Yadid"' showing total 8 results
Start Over "Gal Yadid" Journal plus company updates
8 results on '"Gal Yadid"'

2. Pluri Teams Up with Bar-Ilan University to Create PLX Cells for Cocaine Addiction Therapy

Subjects
Cocaine, Drug abuse -- Care and treatment, Substance abuse -- Care and treatment, General interest, News, opinion and commentary, Bar-Ilan University
Abstract

HAIFA: Pluri Inc., a biotech company, has signed an agreement with BIRAD-Research & Development Company Ltd., the commercial arm of Bar-Ilan University, to develop Pluri's PLX cells for the treatment [...]

Published
2023

3. Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment

Subjects
Cocaine, Drug abuse, Substance abuse -- Care and treatment, General interest, News, opinion and commentary
Abstract

Tel Aviv, Israel / Vancouver, Canada: Clearmind Medicine Inc has issued the following news release: Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) ('Clearmind' or the 'company'), a biotech company [...]

Published
2023

4. Israeli Biotech Clearmind Medicine Announced Positive Pre-Clinical Results Treating Major Depression With a Novel Ketamine-Based Compound

Subjects
Major depressive disorder, Ketamine, Biotechnology, Biotechnology industry, General interest, News, opinion and commentary
Abstract

Tel Aviv: Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (Clearmind or the Company), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major [...]

Published
2023

5. SciSparc Announces Additional Positive Result from the Third Part of Clearmind Medicine Inc. Pre-Clinical Study for Cocaine Addiction Treatment

Subjects
Clinical trials -- Research, Cocaine -- Research, Drug abuse -- Care and treatment -- Research, Substance abuse -- Care and treatment, General interest, News, opinion and commentary
Abstract

TEL AVIV: SciSparc Ltd. (Nasdaq: SPRC) ('Company' or 'SciSparc'), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced [...]

Published
2023

6. Israel-Based Clearmind Issues Additional Positive Results from the Third Part of its Pre-Clinical Study for Cocaine Addiction Treatment

Subjects
Clinical trials -- Research, Cocaine -- Research, Drug abuse -- Research, Substance abuse -- Care and treatment, General interest, News, opinion and commentary
Abstract

Tel Aviv: Clearmind Medicine Inc., a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced additional positive pre-clinical results in its [...]

Published
2023

7. Rising Cases Of Mental Health Disorders of Stress, Anxiety & Addiction Fueling Need for Central Nervous System Therapeutics

Subjects
Biogen Inc., Biological products industry, Multiple sclerosis, Mental health, Evidence-based medicine, Central nervous system, Stress (Psychology), General interest, News, opinion and commentary
Abstract

PALM BEACH: FinancialNewsMedia.com has issued the following news release: FinancialNewsMedia.com News Commentary - The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic and [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results